| Document Date: 2011-11-18 09:13:50
Open Document File Size: 129,36 KBShare Result on Facebook
City Langhorne / / Company ALL / EUSA Pharma (USA) Inc. / / Country United States / / Event FDA Phase / / Facility National Cancer Institute / / IndustryTerm injection site / treatment of patients with acute lymphoblastic leukemia / cooperative / resuscitation equipment / colorless solution / treatment protocol / / MedicalCondition Glucose intolerance / leukemia / abdominal pain / Allergic Reactions Hypersensitivity / Allergic Reaction / lymphoma / chest pain / Disseminated Intravascular Coagulation / disease / headache / shortness of breath / Carcinogenesis / Seizure Seizure / hyperglycemia / Hyperglycemia Hyperglycemia / nausea / cerebral venous thrombosis / anaphylaxis / Diarrhea Diarrhea / hyperlipidemia / hepatobiliary disorders / Glucose Intolerance Glucose intolerance / allergy / acute lymphoblastic leukemia / serious hypersensitivity / Pancreatitis Pancreatitis / vomiting / Severe pancreatitis / Headache Headache / Systemic Allergic Reactions / Urticaria / pancreatitis / allergic reactions / sagittal sinus thrombosis / hypersensitivity / systemic hypersensitivity / hemorrhagic pancreatitis / pancreatic disorders / Thrombosis / serious pancreatitis / serious thrombosis / Abnormalities Transient Ischemic Attack / mild pancreatitis / / MedicalTreatment treatment protocol / resuscitation / chemotherapy / insulin therapy / / Organization National Cancer Institute / DOSAGE AND ADMINISTRATION / FDA / / / Position physician / / Product sodium chloride / ERWINAZE powder / / ProvinceOrState Pennsylvania / / Technology Pharmacokinetics / treatment protocol / antibodies / chemotherapy / / URL www.fda.gov/medwatch / /
SocialTag |
ERWINAZE (asparaginase Erwinia chrysanthemi)